Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
SHINGRIX Patient Information Booklet
Implementing the Shingles National Immunisation Programme: Importance of the 2nd Dose
Are you inviting your patients to dedicated shingles clinics to receive their second dose?
Learn more about why it's important for your patients to complete the full 2-dose SHINGRIX vaccination course and strategies to ensure your patients receive both doses.
SHINGRIX is given as a 2-dose schedule.1,2,3 The second dose is not a booster dose.
It is important to complete the full 2-dose vaccination course. This will maximise the protection offered by the vaccine against shingles.
GSK has developed a number of resources for healthcare professionals to use with SHINGRIX patients to help support implementation of the programme. These include:
1. SHINGRIX Patient Information Booklet
- This item has been developed for patients who are attending their GP Practice for their 1st SHINGRIX dose. It includes information about shingles, the vaccine, side effect reporting and 2nd dose compliance.
2. SHINGRIX Vaccination Record and Appointment Reminder Card
- This item has been developed for patients who are attending their GP Practice for their 1st SHINGRIX dose. Once completed, it will provide the patient with a reminder of the date of their appointment for their 2nd dose. It will also serve as a vaccination record for the patient.
3. Shingles Vaccination Digital Second Dose Reminder: QR code tent card
- This item has been developed to support your patients with receiving both doses of the shingles vaccination.
- The QR code can be scanned by a patient using their phone camera once they have had their first dose. They will be directed to a GSK pop-up to consent to place a reminder at 6 months, to book in for their 2nd dose
Links lead to GSKpro Webshop page where materials can be ordered.
1. Templates
Proactively running regular searches for patients eligible for their 2nd dose all year round can be an effective way to ensure eligible patients are consistently being booked in to complete their vaccination schedule.
Once you've identified your eligible 2nd dose patients, invite them for an appointment. Invitations can be via email, letter or telephone, depending on your practice systems and patient preference. Please find below some example wording for texts and letter invitations.
An example text message that can be sent to your patients requiring their second dose.
“Dear [Patient’s Name],
It’s time to book your second dose of the free NHS shingles vaccination.
Two doses of the shingles vaccine are needed to maximise the protection it offers against shingles. For optimal protection from shingles, please ensure you receive your second dose.
Shingles is a painful condition, caused by the reactivation of the virus that causes chickenpox, that can disrupt daily life for weeks. In the UK, there is an estimated 1 in 4 lifetime risk of developing shingles.3
Please contact us to book your second dose of your shingles vaccination.
Best Regards,
[Healthcare Provider Name]
[Practice Phone Number]”
An example letter/email that can be sent to your patients requiring their second dose.
“Dear [Patient’s Name],
It’s time to book your second dose of the free NHS shingles vaccination.
Two doses of the shingles vaccine are needed to maximise the protection it offers against shingles. For optimal protection from shingles, please ensure you receive your second dose.
Shingles is a painful condition, caused by the reactivation of the virus that causes chickenpox, that can disrupt daily life for weeks. In the UK, there is an estimated 1 in 4 lifetime risk of developing shingles.3
Please book your second dose of your shingles vaccination using the link [insert clinic appointment booking link] or contact the practice at [Practice Phone Number].
Best Regards,
[Healthcare Provider Name]
[Clinic Phone Number]”
References:
- SHINGRIX. Summary of Product Characteristics (Great Britain)
- SHINGRIX. Summary of Product Characteristics (Northern Ireland)
- DH Green Book: Ch28a Shingles (Mar 2024)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441 or UK.Safety@gsk.co.uk
SHINGRIX is owned by or licensed to the GSK group of companies.
© 2024 GSK group of companies or its licensor.
Trade marks are owned by or licensed to the GSK group of companies.
January 2025 | PM-GB-SGX-WCNT-240028 (V1.0)
